Merck KGaA announced that Group total revenues rose 2.1 % in 2009 – meeting the guidance given earlier in the year. Total revenues for the Group reached Euro 7,747 million as the 6.5 % increase in revenues from the Pharmaceuticals business sector more than offset the 9.0 % decline in revenues from the Chemicals business sector. During the fourth quarter, Merck recorded a 5.9 % increase in total revenues to Euro 2,029 million. Merck had no major acquisitions or divestments during 2009.
Share:
